29 research outputs found
The problematic backreaction of SUSY-breaking branes
In this paper we investigate the localisation of SUSY-breaking branes which,
in the smeared approximation, support specific non-BPS vacua. We show, for a
wide class of boundary conditions, that there is no flux vacuum when the branes
are described by a genuine delta-function. Even more, we find that the smeared
solution is the unique solution with a regular brane profile. Our setup
consists of a non-BPS AdS_7 solution in massive IIA supergravity with smeared
anti-D6-branes and fluxes T-dual to ISD fluxes in IIB supergravity.Comment: 27 pages, Latex2e, 5 figure
Instantons and Killing spinors
We investigate instantons on manifolds with Killing spinors and their cones.
Examples of manifolds with Killing spinors include nearly Kaehler 6-manifolds,
nearly parallel G_2-manifolds in dimension 7, Sasaki-Einstein manifolds, and
3-Sasakian manifolds. We construct a connection on the tangent bundle over
these manifolds which solves the instanton equation, and also show that the
instanton equation implies the Yang-Mills equation, despite the presence of
torsion. We then construct instantons on the cones over these manifolds, and
lift them to solutions of heterotic supergravity. Amongst our solutions are new
instantons on even-dimensional Euclidean spaces, as well as the well-known
BPST, quaternionic and octonionic instantons.Comment: 40 pages, 2 figures v2: author email addresses and affiliations adde
Fractional branes, warped compactifications and backreacted orientifold planes
The standard extremal p-brane solutions in supergravity are known to allow
for a generalisation which consists of adding a linear dependence on the
world-volume coordinates to the usual harmonic function. In this note we
demonstrate that remarkably this generalisation goes through in exactly the
same way for p-branes with fluxes added to it that correspond to fractional
p-branes. We relate this to warped orientifold compactifications by trading the
Dp-branes for Op-planes that solve the RR tadpole condition. This allows us to
interpret the worldvolume dependence as due to lower-dimensional scalars that
flow along the massless directions in the no-scale potential. Depending on the
details of the fluxes these flows can be supersymmetric domain wall flows. Our
solutions provide explicit examples of backreacted orientifold planes in
compactifications with non-constant moduli.Comment: 20 pages, incl. references. v2: small changes required for JHEP
publication. v3: few equation typos correcte
D3-brane Potentials from Fluxes in AdS/CFT
We give a comprehensive treatment of the scalar potential for a D3-brane in a
warped conifold region of a compactification with stabilized moduli. By
studying general ultraviolet perturbations in supergravity, we systematically
incorporate `compactification effects' sourced by supersymmetry breaking in the
compact space. Significant contributions to the D3-brane potential, including
the leading term in the infrared, arise from imaginary anti-self-dual (IASD)
fluxes. For an arbitrary Calabi-Yau cone, we determine the most general IASD
fluxes in terms of scalar harmonics, then compute the resulting D3-brane
potential. Specializing to the conifold, we identify the operator dual to each
mode of flux, and for chiral operators we confirm that the potential computed
in the gauge theory matches the gravity result. The effects of four-dimensional
curvature, including the leading D3-brane mass term, arise directly from the
ten-dimensional equations of motion. Furthermore, we show that gaugino
condensation on D7-branes provides a local source for IASD flux. This flux
precisely encodes the nonperturbative contributions to the D3-brane potential,
yielding a promising ten-dimensional representation of four-dimensional
nonperturbative effects. Our result encompasses all significant contributions
to the D3-brane potential discussed in the literature, and does so in the
single coherent framework of ten-dimensional supergravity. Moreover, we
identify new terms with irrational scaling dimensions that were inaccessible in
prior works. By decoupling gravity in a noncompact configuration, then
systematically reincorporating compactification effects as ultraviolet
perturbations, we have provided an approach in which Planck-suppressed
contributions to the D3-brane effective action can be computed.Comment: 70 page
Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature
Early health technology assessment is increasingly being used to support health economic evidence development during early stages of clinical research. Such early models can be used to inform research and development about the design and management of new medical technologies to mitigate the risks, perceived by industry and the public sector, associated with market access and reimbursement. Over the past 25 years it has been suggested that health economic evaluation in the early stages may benefit the development and diffusion of medical products. Early health technology assessment has been suggested in the context of iterative economic evaluation alongside phase I and II clinical research to inform clinical trial design, market access, and pricing. In addition, performing early health technology assessment was also proposed at an even earlier stage for managing technology portfolios. This scoping review suggests a generally accepted definition of early health technology assessment to be “all methods used to inform industry and other stakeholders about the potential value of new medical products in development, including methods to quantify and manage uncertainty”. The present review also aimed to identify recent published empirical studies employing an early-stage assessment of a medical product. With most included studies carried out to support a market launch, the dominant methodology was early health economic modeling. Further methodological development is required, in particular, by combining systems engineering and health economics to manage uncertainty in medical product portfolios